This page is designed to help you ensure your submission is ready for and fits the scope of the journal.

Before submitting you should read over the guidelines here, then register an account (or login if you have an existing account)

---

About

RR\ID is an open-access overlay journal that accelerates peer review of important infectious disease-related research preprints. We are an evolution of Rapid Reviews: COVID-19 (RR\C19), which won the 2022 PROSE Award for Innovation in Journal Publishing for introducing a new peer review model facilitating rapid publishing of COVID-19-related research preprints. RR\ID expands beyond COVID-19 to advance our understanding of infectious diseases, leaning on a similar “curate, review, publish” model. RR\ID aims to prevent the dissemination of false/misleading scientific information and accelerate the validation and diffusion of robust findings. RR\ID aims to increase the application of science for the common good, responding to infectious disease challenges throughout the world.

---

Focus and Scope

This should be updated to reflect your journals focus.

---

---

---

Peer Review

This journal operates a open/single anonymous/double anonymous, peer review policy.

---

Licences

Rapid Reviews\Infectious Diseases allows the following licences for submission:

• Copyright
  © the author(s). All rights reserved.
• CC BY 4.0
  Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
• CC BY-ND 4.0
  Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
• CC BY-NC 4.0
  Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. NonCommercial — You may not use the material for commercial purposes. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
• CC BY-NC-ND 4.0
  Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. NonCommercial — You may not use the material for commercial purposes. NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
• CC BY-SA 4.0
  Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

---

Publication Fees

You should update this section to show any fees that your journal charges.

---

Publication Cycle

This journal published continuously all year round/publishes in issues every x months.

---

Sections

---

---